Amanote Research
Register
Sign In
Topical Aldose Reductase Inhibitor.
British Journal of Ophthalmology
- United Kingdom
doi 10.1136/bjo.79.12.1064
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Neuroscience
Ophthalmology
Sensory Systems
Cellular
Date
December 1, 1995
Authors
D Coster
Publisher
BMJ
Related search
Aldose Reductase Inhibitors: 2013-Present
Expert Opinion on Therapeutic Patents
Medicine
Drug Discovery
Pharmacology
Aldose Reductase in the Retina
Current Enzyme Inhibition
Biochemistry
Drug Discovery
Molecular Medicine
Correction: Epalrestat, an Aldose Reductase Inhibitor, Restores Erectile Function in Streptozocin-Induced Diabetic Rats
International Journal of Impotence Research
Urology
A Multicentre Trial of the Aldose-Reductase Inhibitor, Tolrestat, in Patients With Symptomatic Diabetic Neuropathy
Diabetologia
Internal Medicine
Endocrinology
Metabolism
Diabetes
Clinical and Neurophysiological Studies With the Aldose Reductase Inhibitor, Sorbinil, in Symptomatic Diabetic Neuropathy
Diabetologia
Internal Medicine
Endocrinology
Metabolism
Diabetes
Macrocarpals, Antibacterial Compounds fromEucalyptus, Inhibit Aldose Reductase
Bioscience, Biotechnology and Biochemistry
Organic Chemistry
Applied Microbiology
Molecular Biology
Biochemistry
Analytical Chemistry
Medicine
Biotechnology
GP-1447, an Inhibitor of Aldose Reductase, Prevents the Progression of Diabetic Cataract in Rats
Biological and Pharmaceutical Bulletin
Medicine
Pharmacology
Pharmaceutical Science
Intervention With the Aldose Reductase Inhibitor, Tolrestat, in Renal and Retinal Lesions of Streptozotocin-Diabetic Rats
Diabetologia
Internal Medicine
Endocrinology
Metabolism
Diabetes
Aldose Reductase Expression as a Risk Factor for Cataract
Chemico-Biological Interactions
Medicine
Toxicology